Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -3.01% slid 5.93% to $158.00 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.53% falling 1.25% to 12,938.12 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.22% falling 0.50% to 33,980.32. This was the stock's second consecutive day of losses. Moderna Inc. closed $306.85 below its 52-week high ($464.85), which the company reached on September 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.08% fell 0.78% to $141.44, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +2.71% fell 0.25% to $250.58, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.93% fell 0.48% to $66.42. Trading volume (5.4 M) eclipsed its 50-day average volume of 5.0 M.